Cotinga Pharmaceuticals Inc.
LONDON, A6 · CIK 0001585808 · Biotech · Private
Biopharmaceutical therapeutics for reproductive health and disability support
cotingapharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.0M
- 8 Form D · May 2018
- 101 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $45,758 | |
| Private capital raised | Form D · SEC | $6,101 | |
| Private capital raised | Form D · SEC | $285,000 | |
| Private capital raised | Form D · SEC | $13,796 | |
| Private capital raised· 1 of 3 same day | Form D · SEC | $1,100,000 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $29,085 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $17,415 | |
| Private capital raised | Form D · SEC | $1,580,439 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1886 | SANOSTEM GLOBAL, LLC | — | $3.5M |
| 1887 | Protocol 46 Inc. | — | $410K |
| 1888 | RETROVIROX, INC. | — | — |
| 1889 | Cotinga Pharmaceuticals Inc. | — | $3.0M |
| 1890 | Antlia Bioscience, Inc. | — | $6.9M |
| 1891 | PLEOPHARMA, INC. | — | $17M |
| 1892 | D2G ONCOLOGY, INC. | — | $6.6M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- DOUGLAS ALEXANDERDirector
- BHARATT CHOWRIRADirector
- WAYNE DANTERDirector · Executive Officer
- JOHN DRAKEDirector
- KATHLEEN FERGUSONDirector
- GENE KELLYExecutive Officer
- BRUNO MARUZZODirector
- BRENT NORTONDirector
- DAVID SANDERSONDirector
- ALISON SILVADirector · Executive Officer
- MURRAY WALLACEDirector
- THOMAS WELLNERDirector
- JOHN YOODirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.